Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Garfield

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2004
Results of a phase II multicenter trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancerMarcus A Neubauer, David H Garfield, Paul R Kuerfler, et al.
Cancer Immunology, Immunotherapy : CII|February 12, 2014
PD-1(+) immune cell infiltration inversely correlates with survival of operable breast cancer patientsShenyou Sun, Xiaochun Fei, Yan Mao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Systemic therapy of bronchioloalveolar carcinoma: results of the first IASLC/ASCO consensus conference on bronchioloalveolar carcinomaMark G Kris, Giuseppe Giaccone, Angela Davies, et al.
Cancer|November 11, 2011
Matrix metalloproteinase-2 polymorphisms and clinical outcome of Chinese patients with nonsmall cell lung cancer treated with first-line, platinum-based chemotherapyXueying Zhao, Xun Wang, Wenting Wu, et al.
Journal of Cancer|October 2, 2018
Distribution and Clinical Utility of the 21-gene Recurrence Score in Pure Mucinous Breast Cancer Patients: a case-control studyWei Wang, Xiaosong Chen, Lin Lin, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2004
Results of a phase II multicenter trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancerMarcus A Neubauer, David H Garfield, Paul R Kuerfler, et al.
Cancer Immunology, Immunotherapy : CII|February 12, 2014
PD-1(+) immune cell infiltration inversely correlates with survival of operable breast cancer patientsShenyou Sun, Xiaochun Fei, Yan Mao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Systemic therapy of bronchioloalveolar carcinoma: results of the first IASLC/ASCO consensus conference on bronchioloalveolar carcinomaMark G Kris, Giuseppe Giaccone, Angela Davies, et al.
Cancer|November 11, 2011
Matrix metalloproteinase-2 polymorphisms and clinical outcome of Chinese patients with nonsmall cell lung cancer treated with first-line, platinum-based chemotherapyXueying Zhao, Xun Wang, Wenting Wu, et al.
Journal of Cancer|October 2, 2018
Distribution and Clinical Utility of the 21-gene Recurrence Score in Pure Mucinous Breast Cancer Patients: a case-control studyWei Wang, Xiaosong Chen, Lin Lin, et al.
Pageof 4